MXCT vs WMB · rev $38.6M vs P/E 31, rev $11.95B
MaxCyte Inc (MXCT) versus Williams Companies Inc (WMB) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Williams Companies Inc (WMB) is a oil & gas midstream company listed on NYSE.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported WMB revenue for 2025-12-31 was $11.95B. Net income was $2.62B. Revenue was up 13.8% from 2024-12-31 to 2025-12-31. WMB currently screens at market cap $87.14B and trailing P/E 31.3.
MXCT currently screens at market cap $124.3M. WMB currently screens at market cap $87.14B and trailing P/E 31.3.
Not investment advice. Open the MXCT and WMB stock pages for the full models.
Not investment advice.